Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia. [PDF]
Yañuk DB +12 more
europepmc +1 more source
Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms. [PDF]
Zekanovic I +12 more
europepmc +1 more source
MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies. [PDF]
Wang Y +5 more
europepmc +1 more source
Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming. [PDF]
Carminita E +17 more
europepmc +1 more source
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling for Iron-Regulated Hematopoietic Stem and Progenitor Cells' Commitment toward Erythroid and Megakaryocytic Lineages. [PDF]
Cao K, Fan X, Wong RSM, Yan X.
europepmc +1 more source
The Interconnected World of Coagulation Factors, Platelets and Plasminogen: A Novel Perspective on Biosynthetic Regulation. [PDF]
Bergo I +4 more
europepmc +1 more source
NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms. [PDF]
Koerber RM +15 more
europepmc +1 more source
Asquith NL, Carminita E, Camacho V, et al. The bone marrow is the primary site of thrombopoiesis. Blood. 2024;143(3):272-278. [PDF]
europepmc +1 more source
Danthron as a novel IL-6R agonist promotes thrombopoiesis via the SRC/RAS/MAPK pathway. [PDF]
Liao R +12 more
europepmc +1 more source
Immature platelet fraction and bone marrow findings in hematology. [PDF]
Yamasaki S +6 more
europepmc +1 more source

